RHENMAN & PARTNERS ASSET MANAGEMENT AB – Vertex Pharmaceuticals Incorporated Transaction History
RHENMAN & PARTNERS ASSET MANAGEMENT AB portfolio value:
$29.95M
portfolio value
RHENMAN & PARTNERS ASSET MANAGEMENT AB quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.05% | 1K shares | 3.18M | $289.54 | 96K |
| Q2 2022 | share | Increase | +6.15% | 5.5K shares | 3.41M | $281.79 | 95K |
| Q1 2022 | share | Decrease | -45.76% | -75.5K shares | -13.34M | $260.97 | 89.5K |
| Q4 2021 | share | 0.00% | 0 shares | 6.77M | $222.45 | 165K | |
| Q3 2021 | share | Decrease | -23.57% | -50.89K shares | -13.60M | $181.39 | 165K |
| Q2 2021 | share | Increase | +28.19% | 47.47K shares | 7.33M | $201.63 | 215.89K |
| Q1 2021 | share | Increase | +46.45% | 53.42K shares | 9.01M | $214.89 | 168.42K |
| Q4 2020 | share | Increase | +4.55% | 5K shares | -2.75M | $236.34 | 115K |
| Q3 2020 | share | Decrease | -20.00% | -27.5K shares | -9.98M | $272.12 | 110K |
| Q2 2020 | share | Increase | +19.57% | 22.5K shares | 12.55M | $290.31 | 137.5K |
| Q1 2020 | share | Decrease | -28.13% | -45K shares | -7.66M | $237.95 | 115K |
| Q4 2019 | share | Decrease | -13.98% | -26K shares | 3.52M | $218.95 | 160K |
| Q3 2019 | share | Increase | +0.41% | 768 shares | -2.45M | $169.42 | 186K |
| Q2 2019 | share | Increase | +28.28% | 40.83K shares | 7.40M | $183.38 | 185.23K |
| Q1 2019 | share | Increase | +9.04% | 11.97K shares | 4.61M | $183.95 | 144.4K |
| Q4 2018 | share | Decrease | -7.05% | -10.04K shares | -5.51M | $165.71 | 132.42K |
| Q3 2018 | share | Decrease | -8.09% | -12.53K shares | 1.11M | $192.74 | 142.46K |
| Q2 2018 | share | Increase | +3.33% | 5K shares | 1.89M | $169.96 | 155K |
| Q1 2018 | share | Decrease | -1.45% | -2.20K shares | 1.63M | $162.98 | 150K |
| Q4 2017 | share | Decrease | -15.44% | -27.79K shares | -4.55M | $149.86 | 152.20K |
| Q3 2017 | share | Increase | +89.45% | 84.98K shares | 15.12M | $152.04 | 180K |
| Q2 2017 | share | 0.00% | 0 shares | 1.85M | $128.87 | 95.01K | |
| Q1 2017 | share | Increase | +46.14% | 30K shares | 5.6M | $109.35 | 95.01K |
| Q4 2016 | share | Decrease | -18.75% | -15K shares | -2.18M | $73.67 | 65.01K |
| Q3 2016 | share | Increase | +33.35% | 20.01K shares | 1.81M | $87.21 | 80.01K |
| Q2 2016 | share | Decrease | -23.08% | -18K shares | -1.03M | $86.02 | 60K |
| Q1 2016 | share | Increase | +39.29% | 22K shares | -846K | $79.49 | 78K |